Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015 von Laut, Kamilla, Shepherd, Leah, Radoi, Roxana, Karpov, Igor, Parczewski, Milosz, Mussini, Cristina, Maltez, Fernando, Losso, Marcelo, Chkhartishvili, Nikoloz, Elinav, Hila, Kovari, Helen, Blaxhult, Anders, Zangerle, Robert, Trofimova, Tatiana, Inglot, Malgorzata, Zilmer, Kai, Kuzovatova, Elena, Staub, Thérèse, Raben, Dorthe, Lundgren, Jens, Mocroft, Amanda, Kirk, Ole, On Behalf Of The EuroSIDA Study Group

Volltext

Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study von Amele, Sarah, Peters, Lars, Rodger, Alison, Lundgren, Jens, Rockstroh, Jurgen, Matulionyte, Raimonda, Leen, Clifford, Jabłonowska, Elzbieta, Østergaard, Lars, Bhagani, Sanjay, Sarcletti, Mario, Clarke, Amanda, Falconer, Karolin, Wandeler, Gilles, Domingo, Pere, Maltez, Fernando, Zaccarelli, Mauro, Chkhartisvili, Nikoloz, Szlavik, Janos, Stephan, Christoph, Fonquernie, Laurent, Aho, Inka, Mocroft, Amanda

Volltext

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe von Santos, JR, Cozzi‐Lepri, A, Phillips, A, De Wit, S, Pedersen, C, Lazzarin, A, Sluzhynska, M, Orkin, C, Duvivier, C, Bogner, J, Gargalianos‐Kakolyris, P, Schmid, P, Hassoun, G, Khromova, I, Beniowski, M, Sedlacek, D, Paredes, R, Lundgren, JD, Losso, M, Zangerle, R, Vassilenko, A, Paduto, D, Clumeck, N, Delforge, M, Florence, E, Vandekerckhove, L, Begovac, J, Machala, L, Jilich, D, Benfield, T, Ostergaard, L, Ristola, M, Viard, J.‐P, Girard, P.‐M, Rockstroh, J, Schmidt, R, Degen, O, Stellbrink, H. J, Stefan, C, Sambatakou, H, Szlávik, J, Mulcahy, F, Yust, I, Sthoeger, Z. M, D'Arminio Monforte, A, Mussini, C, Mazzotta, F, Vullo, V, Zaccarelli, M, Antinori, A, Acinapura, R, Plazzi, M, Gianotti, N, Galli, M, Ridolfo, A, Matulionyte, R, Staub, T, Bruun, J, Gasiorowski, J, Pynka, M, Mularska, E, Gensing, M, Jablonowska, E, Mansinho, K, Maltez, F, Radoi, R, Panteleev, A, Panteleev, O, Trofimora, T, Borodulina, E, Vdoushkina, E, Gatell, J. M, Moreno, S, Rodriguez, J. M, Clotet, B, Tural, C, Puig, J, Bravo, I, Mateo, G, Sambeat, M. A, Thalme, A, Cavassini, M, Calmy, A, Furrer, H, Battegay, M, Kuznetsova, A, Kyselyova, G, Simons, E, Edwards, S, Johnson, M. A, Mocroft, A, Weber, J, Clarke, A, Gatell, J, Matthews, C, Fischer, A. H, Raben, D, Grønborg Laut, K, Larsen, J. F, Schultze, A

Volltext

Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study von VAN LUIN, Matthijs, BANNISTER, Wendy P, LUNDGREN, Jens D, BURGER, David M, MOCROFT, Amanda, REISS, Peter, DI PERRI, Giovanni, PEYTAVIN, Gilles, MOLTO, José, KARLSON, Anders, CASTAGNA, Antonella, BENIOWSKI, Marek

Volltext

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens von Cozzi-Lepri, A, Zangerle, R, Machala, L, Zilmer, K, Ristola, M, Pradier, C, Kirk, O, Sambatakou, H, Faetkenheuer, G, Yust, I, Schmid, P, Gottfredsson, M, Khromova, I, Jilich, D, Flisiak, R, Smidt, J, Rozentale, B, Radoi, R, Losso, MH, Lundgren, JD, Mocroft, A, EuroSIDA study group, on behalf of the, Vandekerckhove, Linos

Volltext

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study von CABRERA, Cecilia, COZZI-LEPRI, Alessandro, CLOTET, Bonaventura, RUIZ, Lidia, PHILLIPS, Andrew N, LOVEDAY, Clive, KIRK, Ole, AITKHALED, Mounir, REISS, Peter, KJOER, Jesper, LEDERGERBER, Bruno, LUNDGREN, Jens D

Volltext

P19 Response to second‐line protease‐inhibitor (PI) regimens: results from the EuroSIDA study von Mocroft, A, Phillips, An, Miller, V, Gatell, J, Van Lunzen, J, Lazzarin, A, On, Jd Lundgren, Of, Behalf, Group, The EuroSida Study

Volltext